FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138004881> ?p ?o ?g. }

• W2138004881 endingPage "40" @default.
• W2138004881 startingPage "34" @default.
• W2138004881 abstract "<h3>BACKGROUND AND PURPOSE:</h3> Endoluminal reconstruction with flow diverting devices represents a novel constructive technique for the treatment of cerebral aneurysms. We present the results of the first prospective multicenter trial of a flow-diverting construct for the treatment of intracranial aneurysms. <h3>MATERIALS AND METHODS:</h3> Patients with unruptured aneurysms that were wide-necked (>4 mm), had unfavorable dome/neck ratios (<1.5), or had failed previous therapy were enrolled in the PITA trial between January and May 2007 at 4 (3 European and 1 South American) centers. Aneurysms were treated with the PED with or without adjunctive coil embolization. All patients underwent clinical evaluation at 30 and 180 days and conventional angiography 180 days after treatment. Angiographic results were adjudicated by an experienced neuroradiologist at a nonparticipating site. <h3>RESULTS:</h3> Thirty-one patients with 31 intracranial aneurysms (6 men; 42–76 years of age; average age, 54.6 years) were treated during the study period. Twenty-eight aneurysms arose from the ICA (5 cavernous, 15 parophthalmic, 4 superior hypophyseal, and 4 posterior communicating segments), 1 from the MCA, 1 from the vertebral artery, and 1 from the vertebrobasilar junction. Mean aneurysm size was 11.5 mm, and mean neck size was 5.8 mm. Twelve (38.7%) aneurysms had failed (or recurred after) a previous endovascular treatment. PED placement was technically successful in 30 of 31 patients (96.8%). Most aneurysms were treated with either 1 (<i>n</i> = 18) or 2 (<i>n</i> = 11) PEDs. Fifteen aneurysms (48.4%) were treated with a PED alone, while 16 were treated with both PED and embolization coils. Two patients experienced major periprocedural stroke. Follow-up angiography demonstrated complete aneurysm occlusion in 28 (93.3%) of the 30 patients who underwent angiographic follow-up. No significant in-construct stenosis (≥50%) was identified at follow-up angiography. <h3>CONCLUSIONS:</h3> Intracranial aneurysm treatment with the PED is technically feasible and can be achieved with a safety profile analogous to that reported for stent-supported coil embolization. PED treatment elicited a very high rate (93%) of complete angiographic occlusion at 6 months in a population of the most challenging anatomic subtypes of cerebral aneurysms." @default.
• W2138004881 created "2016-06-24" @default.
• W2138004881 creator A5015183472 @default.
• W2138004881 creator A5030488381 @default.
• W2138004881 creator A5042641612 @default.
• W2138004881 creator A5059036451 @default.
• W2138004881 creator A5062195334 @default.
• W2138004881 creator A5079563436 @default.
• W2138004881 date "2010-12-09" @default.
• W2138004881 modified "2023-10-17" @default.
• W2138004881 title "The Pipeline Embolization Device for the Intracranial Treatment of Aneurysms Trial" @default.
• W2138004881 cites W1972121983 @default.
• W2138004881 cites W1972169575 @default.
• W2138004881 cites W1982810164 @default.
• W2138004881 cites W1984096471 @default.
• W2138004881 cites W1991385448 @default.
• W2138004881 cites W1991456626 @default.
• W2138004881 cites W1999124647 @default.
• W2138004881 cites W2005459712 @default.
• W2138004881 cites W2044313202 @default.
• W2138004881 cites W2049457167 @default.
• W2138004881 cites W2057324898 @default.
• W2138004881 cites W2070626593 @default.
• W2138004881 cites W2085294070 @default.
• W2138004881 cites W2106658317 @default.
• W2138004881 cites W2112804733 @default.
• W2138004881 cites W2113516725 @default.
• W2138004881 cites W2125620083 @default.
• W2138004881 cites W2132610783 @default.
• W2138004881 cites W2148226141 @default.
• W2138004881 cites W2149285581 @default.
• W2138004881 cites W2166267105 @default.
• W2138004881 cites W2405712291 @default.
• W2138004881 cites W4256110463 @default.
• W2138004881 doi "https://doi.org/10.3174/ajnr.a2421" @default.
• W2138004881 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7964968" @default.
• W2138004881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21148256" @default.
• W2138004881 hasPublicationYear "2010" @default.
• W2138004881 type Work @default.
• W2138004881 sameAs 2138004881 @default.
• W2138004881 citedByCount "678" @default.
• W2138004881 countsByYear W21380048812012 @default.
• W2138004881 countsByYear W21380048812013 @default.
• W2138004881 countsByYear W21380048812014 @default.
• W2138004881 countsByYear W21380048812015 @default.
• W2138004881 countsByYear W21380048812016 @default.
• W2138004881 countsByYear W21380048812017 @default.
• W2138004881 countsByYear W21380048812018 @default.
• W2138004881 countsByYear W21380048812019 @default.
• W2138004881 countsByYear W21380048812020 @default.
• W2138004881 countsByYear W21380048812021 @default.
• W2138004881 countsByYear W21380048812022 @default.
• W2138004881 countsByYear W21380048812023 @default.
• W2138004881 crossrefType "journal-article" @default.
• W2138004881 hasAuthorship W2138004881A5015183472 @default.
• W2138004881 hasAuthorship W2138004881A5030488381 @default.
• W2138004881 hasAuthorship W2138004881A5042641612 @default.
• W2138004881 hasAuthorship W2138004881A5059036451 @default.
• W2138004881 hasAuthorship W2138004881A5062195334 @default.
• W2138004881 hasAuthorship W2138004881A5079563436 @default.
• W2138004881 hasBestOaLocation W21380048811 @default.
• W2138004881 hasConcept C126838900 @default.
• W2138004881 hasConcept C141071460 @default.
• W2138004881 hasConcept C164705383 @default.
• W2138004881 hasConcept C2775841333 @default.
• W2138004881 hasConcept C2776035437 @default.
• W2138004881 hasConcept C2776098176 @default.
• W2138004881 hasConcept C2778333808 @default.
• W2138004881 hasConcept C2778749279 @default.
• W2138004881 hasConcept C2780405337 @default.
• W2138004881 hasConcept C2780643987 @default.
• W2138004881 hasConcept C541997718 @default.
• W2138004881 hasConcept C71924100 @default.
• W2138004881 hasConceptScore W2138004881C126838900 @default.
• W2138004881 hasConceptScore W2138004881C141071460 @default.
• W2138004881 hasConceptScore W2138004881C164705383 @default.
• W2138004881 hasConceptScore W2138004881C2775841333 @default.
• W2138004881 hasConceptScore W2138004881C2776035437 @default.
• W2138004881 hasConceptScore W2138004881C2776098176 @default.
• W2138004881 hasConceptScore W2138004881C2778333808 @default.
• W2138004881 hasConceptScore W2138004881C2778749279 @default.
• W2138004881 hasConceptScore W2138004881C2780405337 @default.
• W2138004881 hasConceptScore W2138004881C2780643987 @default.
• W2138004881 hasConceptScore W2138004881C541997718 @default.
• W2138004881 hasConceptScore W2138004881C71924100 @default.
• W2138004881 hasIssue "1" @default.
• W2138004881 hasLocation W21380048811 @default.
• W2138004881 hasLocation W21380048812 @default.
• W2138004881 hasLocation W21380048813 @default.
• W2138004881 hasOpenAccess W2138004881 @default.
• W2138004881 hasPrimaryLocation W21380048811 @default.
• W2138004881 hasRelatedWork W2016435426 @default.
• W2138004881 hasRelatedWork W2036963607 @default.
• W2138004881 hasRelatedWork W2060242230 @default.
• W2138004881 hasRelatedWork W2347535912 @default.
• W2138004881 hasRelatedWork W2398409279 @default.
• W2138004881 hasRelatedWork W2407582721 @default.
• W2138004881 hasRelatedWork W2415380953 @default.

• next